Posted in | News | Coal | Mining Business

Rio Tinto Increases Stake in Riversdale Mining

Riversdale Mining is still a prime target for Rio Tinto and the global mining giant is working steadily to seal the deal. It raised its offer of $16 a share to $16.50 a share last week and managed to increase the value of the Africa focused mining company to $4 billion. This also saw it get a higher support from existing shareholders up from about 26% on March 14 to around 30% after the deal sweetener was announced.

The main problem for Rio Tinto in the acquisition of Riversdale Mining are majority share holders Tata Steel from India and CSN from Brazil. These two conglomerates control around 47% of Riversdale while Rio Tinto has barely got a 20% stake in the mining firm.

Once Rio Tinto announced its takeover bid last December both the companies have been steadily increasing their respective stakes in Riversdale Mining to have a more decisive word in how the deal goes through. There is even the chance that Brazilian state owned CSN may launch its own separate bid for the mining firm.

What makes Riversdale Mining such an attractive target is the two major coal projects that it controls in Mozambique and a colliery that it operated in South Africa. The mining and steel companies are both interested in acquiring a say in the sale of the coal it produces.

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, March 19). Rio Tinto Increases Stake in Riversdale Mining. AZoMining. Retrieved on February 22, 2024 from https://www.azomining.com/News.aspx?newsID=3717.

  • MLA

    Scanlon, Joel. "Rio Tinto Increases Stake in Riversdale Mining". AZoMining. 22 February 2024. <https://www.azomining.com/News.aspx?newsID=3717>.

  • Chicago

    Scanlon, Joel. "Rio Tinto Increases Stake in Riversdale Mining". AZoMining. https://www.azomining.com/News.aspx?newsID=3717. (accessed February 22, 2024).

  • Harvard

    Scanlon, Joel. 2019. Rio Tinto Increases Stake in Riversdale Mining. AZoMining, viewed 22 February 2024, https://www.azomining.com/News.aspx?newsID=3717.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit
Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Azthena logo with the word Azthena

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.